Check out our latest #whitepaper containing clinical trial data, real-world evidence, and example algorithms that detail how T2Candida can be incorporated into practice and improve care for invasive candidiasis in your own practice.
- March 31, 2023
Speakers: Dr. Thomas Walsh and Dr. Tamara Seitz
Chairs: Dr. Sarah Delliere and Dr. Aparna Ahuja
Culture-independent diagnostics are charting a new, albeit much-needed course in managing patients impacted by sepsis by aiding in the early identification of pathogens and resistance genes to improve patient outcomes and strengthen existing stewardship programs. The clinical impact of novel culture-independent diagnostics on patients impacted by COVID-19, sepsis, and resistant bacterial pathogens will be discussed with the goal to understand and evolve beyond the existing gold-standard diagnostic methods that remain limited by their sensitivity and extended time to identification.